These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 9400788)
1. Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial. The Optic Neuritis Study Group. Arch Ophthalmol; 1997 Dec; 115(12):1545-52. PubMed ID: 9400788 [TBL] [Abstract][Full Text] [Related]
2. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Beck RW; Gal RL; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Moke PS; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Trobe JD; Wall M; Xing D; Am J Ophthalmol; 2004 Jan; 137(1):77-83. PubMed ID: 14700647 [TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. Beck RW; Cleary PA; Anderson MM; Keltner JL; Shults WT; Kaufman DI; Buckley EG; Corbett JJ; Kupersmith MJ; Miller NR N Engl J Med; 1992 Feb; 326(9):581-8. PubMed ID: 1734247 [TBL] [Abstract][Full Text] [Related]
4. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Cole SR; Beck RW; Moke PS; Gal RL; Long DT Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1017-21. PubMed ID: 10752936 [TBL] [Abstract][Full Text] [Related]
5. The SKILL Card test in optic neuritis: experience of the Optic Neuritis Treatment Trial. Smith-Kettlewell Institute Low Luminance. Optic Neuritis Study Group. Long DT; Beck RW; Moke PS; Blair RC; Kip KE; Gal RL; Katz BJ J Neuroophthalmol; 2001 Jun; 21(2):124-31. PubMed ID: 11450903 [TBL] [Abstract][Full Text] [Related]
6. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Optic Neuritis Study Group Ophthalmology; 2008 Jun; 115(6):1079-1082.e5. PubMed ID: 17976727 [TBL] [Abstract][Full Text] [Related]
7. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485 [TBL] [Abstract][Full Text] [Related]
9. Association of race/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial. Moss HE; Gao W; Balcer LJ; Joslin CE JAMA Ophthalmol; 2014 Apr; 132(4):421-7. PubMed ID: 24557028 [TBL] [Abstract][Full Text] [Related]
10. The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results. Volpe NJ Arch Ophthalmol; 2008 Jul; 126(7):996-9. PubMed ID: 18625952 [No Abstract] [Full Text] [Related]
11. Color vision defect type and spatial vision in the optic neuritis treatment trial. Schneck ME; Haegerstrom-Portnoy G Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2278-89. PubMed ID: 9344351 [TBL] [Abstract][Full Text] [Related]
12. Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial. Beck RW; Kupersmith MJ; Cleary PA; Katz B Ophthalmology; 1993 May; 100(5):691-7; discussion 697-8. PubMed ID: 8493012 [TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis. Menon V; Mehrotra A; Saxena R; Jaffery NF Indian J Ophthalmol; 2007; 55(5):355-9. PubMed ID: 17699944 [TBL] [Abstract][Full Text] [Related]
14. Clinical profile of Malay children with optic neuritis. Shatriah I; Adlina AR; Alshaarawi S; Wan-Hitam WH Pediatr Neurol; 2012 May; 46(5):293-7. PubMed ID: 22520350 [TBL] [Abstract][Full Text] [Related]
17. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. Keltner JL; Johnson CA; Cello KE; Dontchev M; Gal RL; Beck RW; Arch Ophthalmol; 2010 Mar; 128(3):330-7. PubMed ID: 20212204 [TBL] [Abstract][Full Text] [Related]
18. High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Beck RW; Trobe JD; Moke PS; Gal RL; Xing D; Bhatti MT; Brodsky MC; Buckley EG; Chrousos GA; Corbett J; Eggenberger E; Goodwin JA; Katz B; Kaufman DI; Keltner JL; Kupersmith MJ; Miller NR; Nazarian S; Orengo-Nania S; Savino PJ; Shults WT; Smith CH; Wall M; Arch Ophthalmol; 2003 Jul; 121(7):944-9. PubMed ID: 12860795 [TBL] [Abstract][Full Text] [Related]
19. Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: a clinical case series. Sethi HS; Menon V; Sharma P; Khokhar S; Tandon R Indian J Ophthalmol; 2006 Sep; 54(3):177-83. PubMed ID: 16921215 [TBL] [Abstract][Full Text] [Related]
20. The Course of Visual Recovery after Optic Neuritis: Experience of the Optic Neuritis Treatment Trial. Beck RW; Cleary PA; Backlund JC; Ophthalmology; 2020 Apr; 127(4S):S174-S181. PubMed ID: 32200819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]